News

Combining cannabinoids with radiotherapy and smart biomaterials could enhance therapeutic efficacy during the treatment of pancreatic and lung cancers.

The Cancer Research UK Brain Tumour Awards have been launched in partnership with The Brain Tumour Charity.

The aim of the awards is to help advance our understanding about the biology of the disease and the challenges translating discoveries into treatments.

Gathering information before making a decision is considered a hallmark of intelligence. Researchers at the University of Oxford’s Centre for Neural Circuits and Behaviour have discovered what happens in a brain before a decision is made.

Good news, vegans: A new study finds that kimchi made without fish products has the same type of bacteria as more traditionally made kimchi. That finding suggests that any “probiotic” benefits associated with traditional kimchi could be present in vegan versions as well.

A key molecule that is released from fat as a signal to use fatty acids as metabolic fuel is stimulated by both exercise and being cold, a new study suggests.

Nagoya University-centered researchers develop novel system for in vivo real-time monitoring of metabolites in a living mouse brain.

Penn Medicine researchers may have found the reason why some patients with advanced chronic lymphocytic leukemia (CLL) don’t respond to chimeric antigen receptor (CAR) T cell therapy, and the answer is tied to how primed patients’ immune systems are before the therapy is administered.

Researchers show that, in addition to suppressing caterpillar immune systems, wasps also suppress the defense mechanisms of the plants on which the caterpillars feed, which ensures that the caterpillars will continue to provide a suitable environment for the wasps' offspring.

Numerous Florida cancer centers have been awarded $1.36 million to address cancer disparities and improve outcomes and care for individuals affected by pancreatic cancer.

EPFL scientists have developed a new type of "double-bridged peptide" that can be tailored to bind tightly to disease targets of interest. The peptides’ highly efficient binding, combined with their small size and high stability make them ideal for drug therapies.